Noema Pharma: Funding, Investors & Team (Sep 2026)
The primary objective of Noema Pharma, a biotech company founded in 2019 and located in Basel-Stadt, Switzerland, is to create innovative treatments that can effectively manage the most incapacitating symptoms associated with various brain and nervous system conditions that have been neglected by medicine. Noema Pharma's research and development operations revolve around fathoming patient needs and deploying their pioneering therapies.
Noema Pharma has raised $257M across 2 funding rounds on record, the most recent a Series B of $147M announced in Dec 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Noema Pharma Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Noema Pharma Funding Rounds
Noema Pharma raised $109M in a Series B announced in Mar 2023.
1.8 years later, a Series B of $147M was announced in Dec 2024.
Noema Pharma Founders and Leadership Team
Contact details for the Noema Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Noema Pharma Funding Compared to Other Biotechnology Startups
Noema Pharma's latest round of $147M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Noema Pharma in Biotechnology and Basel
Companies Similar to Noema Pharma
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Noema Pharma Funding FAQs
What does Noema Pharma do?
The primary objective of Noema Pharma, a biotech company founded in 2019 and located in Basel-Stadt, Switzerland, is to create innovative treatments that can effectively manage the most incapacitating symptoms associated with various brain and nervous system conditions that have been neglected by medicine. Noema Pharma's research and development operations revolve around fathoming patient needs and deploying their pioneering therapies.
How much funding has Noema Pharma raised?
Noema Pharma has raised $257M across 2 rounds on record. The most recent is a Series B of $147M announced in Dec 2024.
When did Noema Pharma last raise funding?
Noema Pharma's most recent funding round on record is a Series B of $147M, announced in Dec 2024.
Who founded Noema Pharma?
FundedIQ lists Luigi Costa (Founder) at Noema Pharma.
Where is Noema Pharma headquartered?
Noema Pharma is based in Basel, Basel-Stadt, Switzerland.
How many employees does Noema Pharma have?
Noema Pharma is in the 11-50 employee band.
How does Noema Pharma's funding compare to other Biotechnology startups?
Noema Pharma's latest round of $147M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Noema Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Noema Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.